OR WAIT null SECS
© 2023 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
© 2023 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
January 26, 2023
As pharmaceutical market access teams head into 2023, these ten trends detail why evolved preparation, thought, and engagement will be needed to meet post-pandemic marketplace expectations.
January 11, 2023
As new forms of cell and gene therapies continue to be developed, life sciences companies and payers need to find alternative ways to pay for these expensive treatments. Value-based contracts, though slow to gain traction so far, may provide the solution these groups are looking for.
Supporting health plan clinical preparation and financial modeling.
January 05, 2023
Using market access data from day one of your drug development and commercialization journey puts your brand in the best position to succeed at launch.
December 08, 2022
Emerging biopharma companies are critical to the vibrancy of the healthcare landscape, but their long road of drug development fails to translate to successful market launch more often than it does for large pharma. What can be done to improve those odds?
November 17, 2022
Webinar Date/Time: Tuesday, Dec 6, 2022, 11am PT | 2pm ET
November 16, 2022
Webinar Date/Time: Wednesday, November 30, 2022, 1 pm EDT
November 04, 2022
Life sciences professionals will need to keep up with market demand for biologics and biosimilars.
October 18, 2022
Commercial Health Insurance may bring more opportunities for market access in China.
October 11, 2022
Different paths to formulary decision-making.